Callisto Bio-Refineries & Allied Industries Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 05-11-2024
- Paid Up Capital ₹ 0.10 M
as on 05-11-2024
- Company Age 2 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Callisto Bio-Refineries & Allied Industries
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sharmila Kore, Tejraj Kore, Tanvi Kore, and One other member serve as directors at the Company.
- CIN/LLPIN
U23209KA2022PTC163939
- Company No.
163939
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jul 2022
- Date of AGM
22 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Belgaum, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Callisto Bio-Refineries & Allied Industries?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharmila Kore  | Additional Director | Current | |
| Tejraj Kore | Additional Director | Current | |
| Tanvi Kore | Additional Director | 29-Jan-2024 | Current |
| Tanushree Kore | Additional Director | 29-Jan-2024 | Current |
Financial Performance of Callisto Bio-Refineries & Allied Industries.
Callisto Bio-Refineries & Allied Industries Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Callisto Bio-Refineries & Allied Industries?
Unlock access to Callisto Bio-Refineries & Allied Industries's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Callisto Bio-Refineries & Allied Industries?
Callisto Bio-Refineries & Allied Industries has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Callisto Bio-Refineries & Allied Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Callisto Bio-Refineries & Allied Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
